HSTM HEALTHSTREAM INC
Services-Computer Programming, Data Processing, Etc. · Nasdaq · SEC CIK 1095565 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY9.8%
TTM net income YoY-1.0%
TTM EPS YoY2.9%
Revenue 3-yr CAGR5.8%
Net income 3-yr CAGR16.2%
Margins
Gross margin64.7%
Operating margin7.6%
Net margin6.2%
FCF margin21.0%
EBITDA margin21.3%
Returns
ROE5.5%
ROA3.8%
ROIC (approx.)6.0%
Asset turnover0.62x
Leverage & solvency
Liabilities / assets29.0%
Debt / equity0.00x
Current ratio1.48x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.47x
Accruals ratio-9.5%
Payout ratio19.3%
Capex / revenue0.7%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $304.06M | $291.65M |
| Cost of revenue | $107.21M | $97.94M |
| Gross profit | $196.85M | $193.71M |
| R&D expense | $50.98M | $48.89M |
| Operating income | $20.24M | $21.29M |
| Pretax income | $23.22M | $24.80M |
| Income tax | $4.88M | $4.80M |
| Net income | $18.34M | $20.01M |
| EBITDA | $63.71M | $62.53M |
| EPS (basic) | 0.61 | 0.66 |
| EPS (diluted) | 0.61 | 0.66 |
| Dividends declared per share | 0.12 | 0.11 |
| Weighted avg. shares (diluted) | 30.14M | 30.54M |
| Balance sheet | ||
| Cash & equivalents | $36.16M | $59.47M |
| Short-term investments | $20.84M | $37.75M |
| Receivables | $32.15M | $30.19M |
| Current assets | $119.66M | $153.12M |
| PP&E, net | $10.66M | $10.74M |
| Goodwill | $217.52M | $191.22M |
| Intangibles | $64.93M | $55.55M |
| Total assets | $520.37M | $510.77M |
| Current liabilities | $124.15M | $115.69M |
| Total liabilities | $166.35M | $151.41M |
| Shareholders' equity | $354.02M | $359.36M |
| Shares outstanding | 29.58M | 30.43M |
| Cash flow statement | ||
| Operating cash flow | $63.32M | $57.66M |
| Capital expenditure | $3.69M | $1.40M |
| Free cash flow | $59.63M | $56.26M |
| Investing cash flow | -$50.35M | -$33.97M |
| Financing cash flow | -$36.27M | -$4.52M |
| Depreciation & amortization | $43.48M | $41.24M |
| Stock-based compensation | $8.14M | $4.47M |
| Dividends paid | $3.70M | $3.40M |
| Share buybacks | $30.02M | $0 |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.